ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 745617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 745617; 2) Community: the network communities that were significantly associated with the response to NSC 745617; 3) Molecule: the relationships between components within communities and NSC 745617; 4) MDR: the compounds that were significantly associated with the NSC 745617.

NSC Compound Enrichment Correlation
NSC 664563 Null 0.0392716453377535 0.17028598
NSC 697535 Null 0.0392716453377535 0.30421458
NSC 701022 Null 0.0392716453377535 0.0032614565
NSC 711077 Null 0.0392716453377535 0.02119149
NSC 715407 Null 0.0392716453377535 -0.21626284
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0392716453377535 -0.10849336
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0392716453377535 0.080401375
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.13657082
NSC 733476 Null 0.0392716453377535 -0.021814776
NSC 734287 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0392716453377535 0.062253211
Total:40  Current:32    [First] [Prev] [Next] [Last]